Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JOINTSTEM for Cartilage Regeneration in Knee Osteoarthritis
NCT04821102Unknown
- Sponsor
- R Bio
- Start
- Jul 2023
- Primary completion
- Aug 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of JOINTSTEM in osteoarthritis (OA) (2 arms), sponsored by R Bio. Primary endpoint: Cartilage Regeneration Assessment by Arthroscopy at 48 weeks. Status: unknown.
02
Drugs
JOINTSTEM
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04821102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821102.